1-20 of 29
Sort by
News

Comparing Tisa-Cel to Standard of Care in Relapsed/Refractory Aggressive B-Cell NHL

Published: 2022
View News titled, Comparing Tisa-Cel to Standard of Care in Relapsed/Refractory Aggressive B-Cell NHL
News

Researchers Report Positive Early Data for Etavopivat in Sickle Cell Disease

Published: 2022
Abstract
Mid-January 2022
View News titled, Researchers Report Positive Early Data for Etavopivat in Sickle Cell Disease
News

High-Dose Methotrexate Does Not Reduce CNS Relapse in Aggressive B-cell Lymphoma

Published: 2022
Abstract
Mid-January 2022
View News titled, High-Dose Methotrexate Does Not Reduce CNS Relapse in Aggressive B-cell Lymphoma
News

APPs Are Limited in Prescribing Chemotherapy Based on Oncology Setting, Geography

Published: 2022
Abstract
Mid-January 2022
View News titled, APPs Are Limited in Prescribing Chemotherapy Based on Oncology Setting, Geography
News

No Increased Risk of Deep Vein Thrombosis After COVID-19 Vaccination

Published: 2022
Abstract
Mid-January 2022
View News titled, No Increased Risk of Deep Vein Thrombosis After COVID-19 Vaccination
News

GRIFFIN: Daratumumab Combination Maintains Deep Durable Response in Transplant-Eligible Myeloma

Published: 2022
Abstract
Mid-January 2022
View News titled, GRIFFIN: Daratumumab Combination Maintains Deep Durable Response in Transplant-Eligible Myeloma
News

Could Liso-cel Become a New Second-Line Standard for Relapsed/Refractory LBCL?

Published: 2022
Abstract
Mid-January 2022
View News titled, Could Liso-cel Become a New Second-Line Standard for Relapsed/Refractory LBCL?
News

ZUMA-7: Benefits of Axi-Cel Persist Over Current Standard of Care in Aggressive B-Cell Lymphoma

Published: 2022
Abstract
Mid-January 2022
View News titled, ZUMA-7: Benefits of Axi-Cel Persist Over Current Standard of Care in Aggressive B-Cell Lymphoma
News

Evaluating the Safety and Efficacy of Rilzabrutinib in Relapsed/Refractory ITP

Published: 2022
Abstract
Mid-January 2022
View News titled, Evaluating the Safety and Efficacy of Rilzabrutinib in Relapsed/Refractory ITP
News

Mosunetuzumab Plus Polatuzumab Vedotin Shows Promise in Relapsed/Refractory B-Cell NHL

Published: 2022
Abstract
Mid-January 2022
View News titled, Mosunetuzumab Plus Polatuzumab Vedotin Shows Promise in Relapsed/Refractory B-Cell NHL
News

Access to Transfusions Plays Crucial Role in Hospice Decision-Making

Published: 2022
Abstract
Mid-January 2022
View News titled, Access to Transfusions Plays Crucial Role in Hospice Decision-Making
News

Fitusiran Significantly Reduced Bleeding in Hemophilia A and B With Inhibitors

Published: 2022
Abstract
Mid-January 2022
View News titled, Fitusiran Significantly Reduced Bleeding in Hemophilia A and B With Inhibitors
News

Cytopenia Associated With Increased Risk of Cancer Death, Particularly in Black Patients

Published: 2022
Abstract
Mid-January 2022
View News titled, Cytopenia Associated With Increased Risk of Cancer Death, Particularly in Black Patients
News

Rusfertide Leads to Hematocrit Control in Patients With Polycythemia Vera

Published: 2022
Abstract
Mid-January 2022
View News titled, Rusfertide Leads to Hematocrit Control in Patients With Polycythemia Vera
News

Venetoclax Plus FLAG-IDA Shows Promising Responses in Newly Diagnosed AML

Published: 2022
Abstract
Mid-January 2022
View News titled, Venetoclax Plus FLAG-IDA Shows Promising Responses in Newly Diagnosed AML
News

Researchers Identify Specific Genetic Abnormalities Predictive of Myeloid and Lymphoid Malignancies

Published: 2022
Abstract
Mid-January 2022
View News titled, Researchers Identify Specific Genetic Abnormalities Predictive of Myeloid and Lymphoid Malignancies
News

Study Characterizes Mutational Landscape and CHIP-Related Mutations in Hematologic Malignancies

Published: 2022
Abstract
Mid-January 2022
View News titled, Study Characterizes Mutational Landscape and CHIP-Related Mutations in Hematologic Malignancies
News

ASH Updates Clinical Practice Guidelines on Post-Discharge Anticoagulation Use in Patients With COVID-19

Published: 2022
Abstract
Mid-January 2022
View News titled, ASH Updates Clinical Practice Guidelines on Post-Discharge Anticoagulation Use in Patients With COVID-19
News

Isatuximab Plus RVd Improves MRD Negativity Rates in Patients With Newly Diagnosed Multiple Myeloma

Published: 2021
Abstract
Mid-January 2022
View News titled, Isatuximab Plus RVd Improves MRD Negativity Rates in Patients With Newly Diagnosed Multiple Myeloma
News

Daratumumab-KRd Quadruplet Therapy, AHCT, and Consolidation Therapy Lead to High MRD Negativity in Newly Diagnosed Myeloma

Published: 2021
Abstract
Mid-January 2022
View News titled, Daratumumab-KRd Quadruplet Therapy, AHCT, and Consolidation Therapy Lead to High MRD Negativity in Newly Diagnosed Myeloma